MedPath

Comparison of the drugs seizure control

Phase 3
Conditions
Episodic and paroxysmal disorders
Seizure.
G40-47
Registration Number
IRCT2013071113956N1
Lead Sponsor
Research Assistant zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

we enrolled children who were experiencing convulsions while attending emergency rooms and whose seizures were not controlled by a bolus of intravenous diazepam (0.2 mg/kg) within 5 min. We excluded children with a history of adverse reactions to sodium sodium valproate or similar drugs, a history of uncontrolled bleeding, thrombocytopaenia, active hepatic disease, cardiac rhythm disturbances orthostatic hypotension, or syncope.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to treatment. Timepoint: once after intervention then 20 minutes later. Method of measurement: View seizure control or lack of control.;Recovery time. Timepoint: once after intervention then 20 minutes later. Method of measurement: measurement duration of seizure control with time unit(minite).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath